Key result
Fast-track management after TA-TAVI succeeded in 83% of patients, with failure independently predicted by age ≥85, EF ≤30%, moderate-to-severe mitral regurgitation, and prolonged fluoroscopy time.
Why the study?
What is the success rate and what are the predictors of failure for a fast-track management protocol in high-risk patients undergoing transapical transcatheter aortic valve implantation?
Cohort (n=207)
No
What is the success rate and what are the predictors of failure for a fast-track management protocol in high-risk patients undergoing transapical transcatheter aortic valve implantation?
Fast-track management following TA-TAVI is safe and successful in the majority of patients, though failure is associated with worse outcomes and is predicted by advanced age, low ejection fraction, significant mitral regurgitation, and prolonged fluoroscopy time.
Answers are grounded in this paper and cite their sources.
Supports fast-track TA-TAVI feasibility in selected patients; leaves open prospective validation of failure predictors.
BACKGROUND: The aim of the current study is to report our experience with fast-track treatment of patients undergoing transapical transcatheter aortic valve implantation (TA-TAVI) and to determine perioperative predictors for fast-track protocol failure. METHODS: Being one of the pioneering centers to start performing TA-TAVI back in 2005, we routinely included patients undergoing this procedure into our fast-track management program since 2008. Between January 2008 and June 2013, 207 consecutive high-risk patients (mean age 79 ± 7 years, mean Log. EuroSCORE 24 ± 10) who underwent TA-TAVI accordingly to our institutional fast-track approach were prospectively collected and analyzed. Uni- and multivariate analysis were performed to identify independent pre- and perioperative predictors of fast-track protocol failure, defined as inability to discharge the patient from the intensive care unit (ICU) on the day of surgery or as readmission to the ICU 48 h after the initial discharge. RESULTS: Fast-track management was successful in 83 % of the patients. 30-day mortality was 8 %. Fast-track protocol failure (17 %) was associated with an outcome worsening compared to the remaining patients (mortality: 40 % vs. 2 % and mean hospital stay: 19 ± 12 vs. 10 ± 9 days; P = .002). Independent predictors of fast-track protocol failure were age ≥85 years (OR 3.1; CI 95 % 1.89-6.21), ejection fraction (EF) ≤30 % (OR 2.6; CI 95 % 1.99-7.52), moderate to severe preoperative mitral valve regurgitation (OR 2.7; CI 95 % 1.27-6.43) and fluoroscopy time ≥12 min (OR 2.9; CI 95 % 1.28-7.46). CONCLUSIONS: Fast-track patient management following TA-TAVI is safe and reproducible in the majority of patients. Besides patient-related preoperative risk factors (age ≥85 years, EF ≤30 % and moderate to severe preoperative mitral valve regurgitation) a technically challenging intraoperative course as evidenced in a prolonged fluoroscopy time are independent predictors of fast-track protocol failure which is associated with high loss of patient outcome.
No takes yet. Share an insight, caveat, or question.
Papadopoulos et al. (2016) conducted a cohort in High-risk patients undergoing transapical transcatheter aortic valve implantation (TA-TAVI) (n=207). Fast-track protocol was evaluated on Fast-track protocol success. Fast-track management after TA-TAVI succeeded in 83% of patients, with failure independently predicted by age ≥85, EF ≤30%, moderate-to-severe mitral regurgitation, and prolonged fluoroscopy time.
Synapse has enriched 10 related papers. Consider them for comparative context: